Alto Neuroscience (ANRO) Current Assets (2023 - 2026)

Alto Neuroscience has disclosed Current Assets across 4 years of filings, most recently posting $269.1 million for Q1 2026.

• Current Assets for Q1 2026 came in at $269.1 million, up 64.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $269.1 million (up 64.58% YoY), and the FY2025 annual result was $177.7 million, up 4.95% from the prior year.
• Current Assets came in at $269.1 million for Q1 2026 at Alto Neuroscience, up from $177.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $269.1 million in Q1 2026 to a low of $85.4 million in Q4 2023.
• The 4-year median for Current Assets is $173.5 million (2024), against an average of $174.2 million.
• Across the five-year window, Current Assets surged 98.31% in 2024 and fell 24.02% in 2025, its largest moves.
• Alto Neuroscience's Current Assets stood at $85.4 million in 2023, then soared by 98.31% to $169.3 million in 2024, then climbed by 4.95% to $177.7 million in 2025, then surged by 51.43% to $269.1 million in 2026.
• The last three Current Assets figures came in at $269.1 million (Q1 2026), $177.7 million (Q4 2025), and $139.4 million (Q3 2025), per Business Quant data.